CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 119 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $223,976 | -29.4% | 173,625 | -5.9% | 0.00% | 0.0% |
| Q2 2023 | $317,330 | +330.1% | 184,494 | +277.6% | 0.00% | – |
| Q1 2023 | $73,773 | +391.8% | 48,856 | +364.3% | 0.00% | – |
| Q3 2022 | $15,000 | -82.4% | 10,523 | -77.5% | 0.00% | – |
| Q2 2022 | $85,000 | -70.2% | 46,683 | -56.3% | 0.00% | -100.0% |
| Q1 2022 | $285,000 | +73.8% | 106,761 | +181.3% | 0.00% | – |
| Q4 2021 | $164,000 | -18.8% | 37,949 | -4.5% | 0.00% | -100.0% |
| Q3 2021 | $202,000 | -95.7% | 39,718 | -94.7% | 0.00% | -94.4% |
| Q2 2021 | $4,737,000 | +649.5% | 748,287 | +815.8% | 0.02% | +350.0% |
| Q1 2021 | $632,000 | +25.6% | 81,713 | +6.4% | 0.00% | 0.0% |
| Q4 2020 | $503,000 | +95.0% | 76,808 | +98.3% | 0.00% | +33.3% |
| Q3 2020 | $258,000 | -73.2% | 38,743 | -66.5% | 0.00% | -81.2% |
| Q2 2020 | $963,000 | +924.5% | 115,664 | +848.8% | 0.02% | +700.0% |
| Q1 2020 | $94,000 | -92.4% | 12,191 | -91.8% | 0.00% | -71.4% |
| Q4 2019 | $1,234,000 | -16.8% | 148,553 | -26.1% | 0.01% | -46.2% |
| Q3 2019 | $1,483,000 | +39.5% | 201,004 | +112.2% | 0.01% | +30.0% |
| Q2 2019 | $1,063,000 | -27.7% | 94,724 | -30.8% | 0.01% | -37.5% |
| Q1 2019 | $1,470,000 | +22.0% | 136,788 | +71.4% | 0.02% | +14.3% |
| Q4 2018 | $1,205,000 | -27.4% | 79,784 | -11.0% | 0.01% | -30.0% |
| Q3 2018 | $1,659,000 | +10.8% | 89,663 | +36.9% | 0.02% | 0.0% |
| Q2 2018 | $1,497,000 | +99.6% | 65,472 | +148.5% | 0.02% | +66.7% |
| Q1 2018 | $750,000 | +55.6% | 26,348 | +15.4% | 0.01% | +50.0% |
| Q4 2017 | $482,000 | +100.8% | 22,837 | +73.0% | 0.01% | +60.0% |
| Q3 2017 | $240,000 | -3.2% | 13,200 | -17.5% | 0.01% | 0.0% |
| Q2 2017 | $248,000 | +37.8% | 16,000 | -2.2% | 0.01% | -28.6% |
| Q4 2016 | $180,000 | – | 16,360 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |